Sort
15,273 grants matching “antimicrobial resistance”
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
$715,118David A Relman · Palo Alto Veterans Instit For Research · R01 · FY2023 · AI
Novel Imaging Tracers for Rapid and Noninvasive Assessment of Bacterial Infection
$714,358Sanjay Jain · Johns Hopkins University · R01 · FY2015 · EB
RNAi-dependent epimutation roles in antimicrobial drug resistance and pathogenesis
$714,221Joseph Heitman · Duke University · R01 · FY2022 · AI
Pharmacokinetics and Pharmacodynamics of Mechanistically Aware Phage Cocktails
$714,053Nicholas Michael Smith · State University Of New York At Buffalo · R01 · FY2024 · AI
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
$713,900H. Anne Pereira · University Of Oklahoma Hlth Sciences Ctr · U01 · FY2007 · AI
Role of inflammation, innate resistance, and immunity in carcinogenesis
$713,277Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
The dynamics of nasal bacterial ecology and S. aureus antagonism
$713,155Lance Bradley Price · George Washington University · R01 · FY2019 · AI
Mechanism of Fungal Virulence Inhibition by a Bacterial Peptide
$713,142Michael C Lorenz · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · AI
Dispersion and the Biofilm Matrix of Pseudomonas aeruginosa
$713,120Karin Sauer · State University Of Ny,Binghamton · R01 · FY2023 · AI
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
$713,033David A Relman · Palo Alto Veterans Instit For Research · R56 · FY2019 · AI
Studies of Receptor Interactions and Effects of Alarmins
$712,775Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Novel Imaging Tracers for Rapid and Noninvasive Assessment of Bacterial Infection
$712,734Sanjay Jain · Johns Hopkins University · R01 · FY2017 · EB
Changing Cultures in Sepsis: Rapid single-cell pathogen identification and antibiotic susceptibility testing directly from whole blood
$712,534Samuel Yang · Stanford University · R01 · FY2024 · AI
Multi-component chlorination intervention to reduce neonatal infections in rural health facilities
$712,090Amy J. Pickering · University Of California Berkeley · R01 · FY2024 · AI
Nitric Oxide-Releasing Wound Dressing for Preventing Chronic Wound Infections
$711,729Nathan Allan Stasko · Novan, Inc. · R44 · FY2012 · AI
Resequencing microarray for rapid detection & antimicrobial resistance profiling
$711,323Susan Veronica Lynch · University Of California, San Francisco · U01 · FY2008 · AI
Staphylococcus aureus SPREAD (S. aureus Study of Prevalence Resistance and Environmental Dissemination)
$710,565Michael Zdenek David · University Of Pennsylvania · R01 · FY2022 · AI
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
$710,534H. Anne Pereira · University Of Oklahoma Hlth Sciences Ctr · U01 · FY2011 · AI
Clinical Impact of Quinolone-Resistant E.coli carriage
$710,193Ebbing Lautenbach · University Of Pennsylvania · R01 · FY2007 · AI
Informatics Approaches to Understand and Reduce Inappropriate Antibiotic Prescribing by Dentists
$710,122Muhammad Walji · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · DE
Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungi
$710,036David R Andes · University Of Wisconsin-Madison · R01 · FY2023 · AI
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
$709,716David A Relman · Palo Alto Veterans Instit For Research · R01 · FY2024 · AI
Regulation of lipid metabolism in bacteria
$709,574Charles O Rock · St. Jude Children'S Research Hospital · R01 · FY2011 · GM
Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses
$709,570Ann R Falsey · University Of Rochester · R01 · FY2023 · AI
Pathogen and immune-topographic mechanisms that underpin Candida auris skin colonization
$709,239Suzanne M Noble · University Of California, San Francisco · R01 · FY2024 · AR